SEC. 2. ENSURING AFFORDABLE COVERAGE OF CERTAIN 
VACCINES AND TESTING SERVICES UNDER 
GROUP HEALTH PLANS AND GROUP AND IN-
DIVIDUAL HEALTH INSURANCE COVERAGE 
DURING 
THE 
COVID-19 
PUBLIC 
HEALTH 
EMERGENCY. 
(a) EXPEDITED MEETING OF ACIP FOR COVID-19 
VACCINES.— 
(1) IN
GENERAL.—Notwithstanding section 
3091 of the 21st Century Cures Act (21 U.S.C. 
360bbb–4 note), the Advisory Committee on Immu-
nization Practices shall meet and issue a rec-
ommendation with respect to a vaccine that is in-
tended to prevent or treat COVID-19 not later than 
15 business days after the date on which such vac-
cine is licensed under section 351 of the Public 
Health Service Act (42 U.S.C. 262). 
(2) DEFINITION.—In this subsection, the term 
‘‘Advisory Committee on Immunization Practices’’ 
means the Advisory Committee on Immunization 
Practices established by the Secretary of Health and 
Human Services pursuant to section 222 of the Pub-
lic Health Service Act (42 U.S.C. 217a), acting 
through the Director of the Centers for Disease 
Control and Prevention. 
VerDate Sep 11 2014 
22:36 Mar 30, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H6231.IH
H6231
jbell on DSKJLSW7X2PROD with BILLS
(b) AUTHORITY TO WAIVE COST SHARING
FOR 
TESTING SERVICES FOR COVID-19.—Section 2713 of the 
Public Health Service Act (42 U.S.C. 300gg–13) is 
amended— 
(1) in the header, by inserting before the period 
at the end the following: ‘‘; COVERAGE OF CER-
TAIN TESTING SERVICES FOR COVID-19’’; and 
(2) by adding at the end the following new sub-
section: 
‘‘(d) COVERAGE
OF CERTAIN TESTING SERVICES 
FOR COVID-19.— 
‘‘(1) IN GENERAL.—A group health plan, and a 
health insurance issuer offering group or individual 
health insurance coverage, shall, during a period de-
scribed in paragraph (2), at a minimum provide cov-
erage for and not impose any cost sharing require-
ments for an item or service specified by the Sec-
retary under paragraph (3) with respect to such pe-
riod. 
‘‘(2) PERIOD
DESCRIBED.—For purposes of 
this subsection and with respect to an item or serv-
ice specified under paragraph (3) and a group health 
plan or group or individual health insurance cov-
erage, a period described in this paragraph is a pe-
riod specified by the Secretary that— 
VerDate Sep 11 2014 
22:36 Mar 30, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H6231.IH
H6231
jbell on DSKJLSW7X2PROD with BILLS
‘‘(A) begins during the public health emer-
gency declared by the Secretary pursuant to 
section 319 on January 31, 2020, entitled ‘De-
termination that a Public Health Emergency 
Exists Nationwide as the Result of the 2019 
Novel Coronavirus’ (or any renewal of such dec-
laration pursuant to such section); and 
‘‘(B) ends on the earlier of— 
‘‘(i) the termination of such declara-
tion; and 
‘‘(ii) in the case the United States 
Preventive Services Task Force issues a 
rating (other than ‘I’) with respect to such 
item or service— 
‘‘(I) in the case such rating is an 
‘A’ or ‘B’, the day before the date on 
which the requirements of subsection 
(a) apply to such plan or coverage 
with respect to such item or service; 
or 
‘‘(II) in the case such rating is 
not described in subclause (I), the 
date such rating is so issued. 
‘‘(3) SPECIFIED
ITEMS
AND
SERVICES.—For 
purposes of this subsection, the Secretary may speci-
VerDate Sep 11 2014 
22:36 Mar 30, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H6231.IH
H6231
jbell on DSKJLSW7X2PROD with BILLS
fy an item or service under this paragraph with re-
spect to a period described in paragraph (2) only if 
such item or service— 
‘‘(A) is a testing service intended to detect 
SARS–CoV–2 or diagnose COVID-19; and 
‘‘(B) does not, as of the date such item or 
service is so specified, have in effect a rating 
from the United States Preventive Services 
Task Force (or has in effect a rating of ‘I’).’’. 
Æ 
VerDate Sep 11 2014 
22:36 Mar 30, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H6231.IH
H6231
jbell on DSKJLSW7X2PROD with BILLS